We are live on ! Find out more
LRMR icon

Larimar Therapeutics
LRMR

93 hedge funds and large institutions have $880M invested in Larimar Therapeutics in 2015 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 32 increasing their positions, 12 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

389% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 9

167% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 12

83% more capital invested

Capital invested by funds: $481M → $880M (+$398M)

60% more funds holding

Funds holding: 58 → 93 (+35)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

Holders
93
Holders Change
+35
Holders Change %
+60.34%
% of All Funds
2.48%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
44
Increased
32
Reduced
12
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
FCMI
Foresite Capital Management II
California
+$119M
2
DM
Deerfield Management
New York
+$41.5M
3
JHIU
Janus Henderson Investors US
Colorado
+$31.2M
4
Jennison Associates
Jennison Associates
New York
+$26.2M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$21.1M

Top Sellers

1
TRV
Third Rock Ventures
Massachusetts
-$55.4M
2
PA
Perceptive Advisors
New York
-$8.58M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$3.81M
4
SFM
Sphera Funds Management
Israel
-$2.22M
5
Principal Financial Group
Principal Financial Group
Iowa
-$1.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
Asset Management One
26
Asset Management One
Japan
$4.91M +$4.84M +10,198 New
JP Morgan Chase
27
JP Morgan Chase
New York
$4.24M -$75.5K -159 -2%
SIM
28
Spark Investment Management
New York
$4.02M +$4.02M +8,470 New
HP
29
Harbourvest Partners
Massachusetts
$4.01M +$4M +8,428 New
CS
30
Candriam SCA
Luxembourg
$3.96M +$3.96M +8,333 New
ACP
31
Acuta Capital Partners
California
$3.96M -$10.4K -22 -0.3%
Northern Trust
32
Northern Trust
Illinois
$3.82M +$972K +2,047 +34%
BBA
33
Baker Bros. Advisors
New York
$3.75M +$3.75M +7,895 New
Geode Capital Management
34
Geode Capital Management
Massachusetts
$3.26M +$1.78M +3,757 +121%
Renaissance Technologies
35
Renaissance Technologies
New York
$3.1M +$3.1M +6,531 New
EAM
36
EverPoint Asset Management
Connecticut
$2.97M +$2.97M +6,250 New
HLA
37
Hamilton Lane Advisors
Pennsylvania
$2.97M +$2.96M +6,245 New
Principal Financial Group
38
Principal Financial Group
Iowa
$2.23M -$1.63M -3,442 -42%
Bank of New York Mellon
39
Bank of New York Mellon
New York
$1.95M +$728K +1,533 +60%
EMFAT
40
Emerald Mutual Fund Advisers Trust
Pennsylvania
$1.88M +$791K +1,666 +57%
UOC
41
UBS O'Connor
Illinois
$1.58M +$1.58M +3,333 New
Citadel Advisors
42
Citadel Advisors
Florida
$1.56M +$1.56M +3,289 New
CCI
43
Columbus Circle Investors
$1.51M +$1.51M +3,177 New
TCIM
44
TIAA CREF Investment Management
New York
$1.47M +$214K +451 +17%
BIM
45
BlackRock Investment Management
Delaware
$1.43M +$648K +1,365 +83%
USAA
46
United Services Automobile Association
Texas
$1.38M +$553K +1,164 +67%
UBS AM
47
UBS AM
Illinois
$1.22M +$1.22M +2,569 New
BlackRock
48
BlackRock
New York
$1.2M +$1.2M +2,522 New
Marshall Wace
49
Marshall Wace
United Kingdom
$1.04M +$1.04M +2,198 New
CS
50
Credit Suisse
Switzerland
$1M +$649K +1,368 +184%
1
2
3 4 5

LRMR Hedge Fund Activity: Q1 2015 in Review

93 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Larimar Therapeutics (LRMR) for Q1 2015, worth a combined $880M — up 83% from $481M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new LRMR positions and 9 closed out — a net gain of 35 holders — while 32 added to existing stakes and 12 trimmed.

The largest buyer was Foresite Capital Management II, adding an estimated $119M. The largest seller was Third Rock Ventures, cutting an estimated $55.4M.

  • 93 institutional investors held Larimar Therapeutics (LRMR) as of Q1 2015, up from 58 in Q4 2014.
  • Funds reported $880M of Larimar Therapeutics stock for Q1 2015, up 83% quarter-over-quarter.
  • 44 funds opened new Larimar Therapeutics positions in Q1 2015 and 9 closed out, a net change of +35 holders.
  • The largest Larimar Therapeutics buyer in Q1 2015 was Foresite Capital Management II, an estimated $119M added.
  • The largest Larimar Therapeutics seller in Q1 2015 was Third Rock Ventures, an estimated $55.4M sold.

Based on aggregated 13F filings for Q1 2015.